SLU-PP-332

What is SLU-PP-332?

SLU-PP-332 is an experimental compound developed by researchers at Washington University. It mimics many of the beneficial effects of long-duration exercise by activating key energy-regulating receptors in your body known as Estrogen-Related Receptors (ERRα, ERRβ, ERRγ). These receptors play a major role in energy metabolism, fat burning, and mitochondrial function.

In simple terms:

SLU-PP-332 tells your body to burn fat, improve endurance, and boost metabolism—similar to the effects of endurance exercise—without having to perform intense physical activity.

Potential Benefits

• Fat Loss Without Exercise: Promotes fat burning independent of diet or physical activity.

• Enhanced Metabolic Health: Helps regulate blood sugar, improve insulin sensitivity, and support healthy cholesterol levels.

• Increased Muscle Function & Endurance: Improves mitochondrial efficiency and muscle stamina.

• Supports Longevity & Organ Health: May reduce metabolic strain on organs, supporting healthy aging.

• Improved Glucose Metabolism: Shown to improve glucose control in preclinical obesity models.

Who May Benefit?

• Individuals struggling with weight loss or metabolic syndrome

• Patients unable to exercise due to injury or chronic illness

• Adults seeking to slow age-related metabolic decline

• Those at risk for type 2 diabetes or cardiovascular disease

• Athletes, biohackers, and longevity enthusiasts

Dosing Protocol

• Dosage: 200mcg by mouth twice daily

  • Take one capsule in the morning before fasted cardio or breakfast.

  • Take the second dose prior to strength training or in the afternoon (if not training, take after lunch).

Cycling Schedule

Initial Cycle:

• 8 weeks ON: Daily use for 8 continuous weeks

• 4 weeks OFF: Discontinue use for 4 weeks to allow metabolic reset and reduce potential adaptation

Why Cycle?

• Prevents receptor desensitization (body becoming resistant)

• Allows your mitochondria and metabolic pathways time to recover

• Helps reduce unknown long-term side effects due to limited safety data

Lab Monitoring Requirements

Because SLU-PP-332 is experimental, careful monitoring is essential. Lab testing allows us to track your response and ensure safety.

Important Safety Notes

• SLU-PP-332 is not FDA approved for human use.

• No human clinical trials exist at this time.

• All use is experimental and should only occur under the supervision of a licensed healthcare provider.

• Full informed consent and careful lab monitoring are required.

Southern Vitality Position Statement

At Southern Vitality, we are committed to offering cutting-edge therapies backed by evolving research. While SLU-PP-332 shows promise as a metabolic and performance-enhancing agent, patient safety remains our top priority. We follow strict protocols, require informed consent, and monitor labs closely throughout use.

Disclaimer: This document is for educational purposes only. SLU-PP-332 has not been evaluated by the FDA and is not approved to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new treatment.